MedDataX Logo

Oral and Anal Swab Sampling in Patients With HPV Positivity

NCT ID: NCT06906913

Last Updated: 2025-04-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-03-14

Study Completion Date

2024-11-19

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patients whose pathology results are reported as cervical intraepithelial neoplasia (CIN) 1, CIN 2, and CIN 3, are recruited. We aimed to evaluate HPV-positive women presenting to the Obstetrics and Gynecology clinic, whose cervical pathology results were reported as CIN 1, CIN 2, and CIN 3, by collecting oropharyngeal and anal swab samples. A total of 30 women of reproductive age, who consented to participate, were included in the study.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Comparison of Cervical Pathologies in the Presence of High Risk Hpv Positivity

NCT03895905

Human Papilloma Virus Cervical Neoplasm
COMPLETED

Acceptability of Self-sampling for Cervical Cancer Screening

NCT05314907

HPV-Related Cervical Carcinoma Self-sampling Cervical Cancer Screening
UNKNOWN NA

Predicting Response In Cervical Intraepithelial Neoplasia to Topical Imiquimod Treatment

NCT05405270

Cervical High Grade Squamous Intraepithelial Lesion Cervical Intraepithelial Neoplasia Grade 2/3 CIN 2/3 +1 more
RECRUITING

HPV Test of Urine and Self Collected Vaginal Samples for Cervical Cancer Screening Study

NCT03409471

ASC-US LSIL
UNKNOWN

Cervical Cancer Screening of Postmenopausal Women in Low- and Middle-income Countries Using HPV Self-sampling and Triage by Genotyping and Cytology

NCT07244315

Cervical Cancer Screening HPV Infections Cervical Intraepithelial Neoplasia
COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Human papillomavirus (HPV) positivity is associated with cervical, oropharyngeal, and anal cancers. There is insufficient data in the current literature regarding the effectiveness of obtaining oropharyngeal and anal swabs from patients with HPV positivity is an effective method for detecting potential pathologies. HPV-positive women presenting to the Obstetrics and Gynecology clinic, whose cervical pathology results were reported as CIN 1, CIN 2, and CIN 3, will be evaluated by collecting oropharyngeal and anal swab samples.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

HPV

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Swab Sampling

Oropharyngeal and anal swab samples are obtained.

HPV testing

Intervention Type DIAGNOSTIC_TEST

Oropharyngeal and anal swab samples are evaluated in the Microbiology laboratory for the existence of HPV.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

HPV testing

Oropharyngeal and anal swab samples are evaluated in the Microbiology laboratory for the existence of HPV.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* HPV-positive women presenting to the Obstetrics and Gynecology clinic, whose cervical pathology results were reported as CIN 1, CIN 2, and CIN 3

Exclusion Criteria

* HPV-negative women
Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

gaziantep university medicine faculty

UNKNOWN

Sponsor Role collaborator

Medipol University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Tugba Akcaoglu

Doctor of Medicine

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Neslihan Bayramoglu Tepe, Doctor of Medicine

Role: STUDY_DIRECTOR

University of Gaziantep

Ozan Dogan, Prof. Dr.

Role: STUDY_CHAIR

Istanbul Nisantasi University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Gaziantep Cengiz Gokcek Women's, Obstetrics and Pediatrics Hospital

Gaziantep, Gaziantep, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TF.HZP.23.31

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

Number 362

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Effectiveness of Cervical Screening in HPV Vaccinated Women
NCT02149030 ACTIVE_NOT_RECRUITING NA
Impact of HPV on a Cohort of Southern Italian Women: Epidemiological, Clinical, Morphological and Microbiological Features
NCT03959410 COMPLETED NA
Predictors of CIN Study Series 5.0:Stability Study in Vaginal Self-samples
NCT02622997 COMPLETED NA
Comparisons of the Effects and Clinical Outcomes of CH2 Vaginal Gel Versus Placebo on CIN1
NCT06582004 ACTIVE_NOT_RECRUITING NA
Use of Human Papillomavirus Persistence for Determination of Treatment Efficacy Among Women With Cervical Dysplasia
NCT00931190 COMPLETED
Feasibility of Sending a Direct Send HPV Self-sampling Kit to Long-term Screening Non-attenders
NCT04909281 COMPLETED
Feasibility and Acceptability of Offering Self-sampling to Non-attendees in Primary Care
NCT02698423 COMPLETED NA
Colposcopic Impression in a Birth Cohort Previously Eligible for HPV-vaccination
NCT04909814 COMPLETED
A Multicenter Cohort Study Assessing the Efficacy and Adverse Effects of HPV Vaccination in Chinese Women
NCT05932576 UNKNOWN
Prevalence of Human Papillomavirus (HPV) in a Healthy Population: A Feasibility Study of Oropharyngeal Cancer Screening
NCT07033091 RECRUITING NA
Gynaecological Follow-up of a Subset of HPV-015 (NCT00294047) Study Subjects
NCT01190176 COMPLETED PHASE3
Determining the Frequency of Occurrence and Defining the Most Appropriate Screening Test for Anal Intraepithelial Neoplasia (AIN) in Patients With Human Papillomavirus (HPV) Related Gynecological Diseases.
NCT06574087 RECRUITING NA
HPV Self-test to Increase Cervical Cancer Screening in Asian Women
NCT04612660 COMPLETED NA
Self-sampling and Human Papillomavirus (HPV)-Testing for Unscreened Women in Cervical Cancer Prevention
NCT01014026 COMPLETED PHASE3
HPV Infections, Cancer of the Vulva and Therapeutical Success
NCT03082950 COMPLETED
HPV Self-Sampling for Cervical Cancer Screening Among Lesbian, Bisexual, and Queer (LBQ) Women
NCT03012932 COMPLETED NA
Non-Invasive Plasma Treatment for Cervical Infections: Targeting High- and Low-Risk HPV Variants
NCT06291311 RECRUITING
Clinic or Self-Sampling for Cervical Cancer Screening
NCT06177236 COMPLETED NA
Evaluating the Impact of Different Methods of HPV DNA Testing for Cervical Cancer Screening in Primary Care Settings
NCT06528184 RECRUITING NA
Evaluation of the Prevalence of Oral HPV Infection in Patients Who Are Positive to the PAP-test
NCT05949398 UNKNOWN
Role of Methylation Test Triage in HPV Positive Women
NCT06366516 NOT_YET_RECRUITING NA
The Human Papilloma Virus Effect on Sexual Life
NCT03837028 COMPLETED
Screening Women With Prior HPV for Anal Neoplasia
NCT05217940 RECRUITING NA
HR-HPV Multi-site Opportunistic Screening in Liaoning, China
NCT03178136 UNKNOWN
Evaluation of ELISA Assay on Human Papilloma Viruses (HPV) Infection Population
NCT00673192 UNKNOWN NA